iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)

CAPS Rating: 4 out of 5

Exchange Traded Funds

IBB News and Commentary

View All IBB News and Commentary

Caps

How do you think IBB will perform against the market?

Add Stock to CAPS Watchlist

All Players

319 Outperform
21 Underperform
 

All-Star Players

94 Outperform
3 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top IBB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mhammond00 (< 20)
Submitted April 05, 2015

If the previous 30 years were dominated by a semiconductor / IT revolution, the next 30 will be dominated by biotech. I'm a scientist working now at a large biotech, but I'm not a biologist by training (I'm a physicist - used to work in… More

NetscribeETF (< 20)
Submitted February 26, 2007

With health care progressing towards personalized medicines, modular diagnosis and such advanced areas, its is only natural to assume that biotech companies will be making the hay while the sun shines. Contrary to expectations the year 2006 brought… More

IBB VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about IBB.

Recs

0
Member Avatar murphey (< 20) Submitted: 5/20/2017 11:32:43 AM : Outperform Start Price: $290.36 IBB Score: +7.78

Immunology and Biotechnology will be increasingly significant in the Health and Medical fiels.

Recs

0
Member Avatar adamicius (< 20) Submitted: 2/28/2017 4:07:50 PM : Outperform Start Price: $300.32 IBB Score: +3.87

Biotechs as a whole a close to breaking out. I like many individual biotechs, but the cost of fees from each would be prohibitive. That's where an ETF is handy, although I hate the expense ratio. IBB is the only ETF I own.

Recs

0
Member Avatar MightyMinnow (48.59) Submitted: 12/8/2016 7:49:56 AM : Outperform Start Price: $264.65 IBB Score: +11.99

Trump's intimate domain policies will still pay a good price. Meds get tax/regulation breaks under Trump too.

Leaderboard

Find the members with the highest scoring picks in IBB.

Score Leader

K2Vancouver

K2Vancouver (76.42) Score: +259.15

The Score Leader is the player with the highest score across all their picks in IBB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
meakulka < 20 9/18/2006 Outperform 3Y $70.76 +356.34% +99.03% +257.31 0 Comment
oldbob1 < 20 9/19/2006 Outperform 3M $70.79 +356.16% +99.65% +256.50 0 Comment
malcolmspetrie 62.53 9/12/2006 Outperform 3W $70.65 +357.04% +100.57% +256.47 0 Comment
TMFWarburs < 20 7/13/2006 Outperform 3M $69.66 +363.54% +110.21% +253.33 0 Comment
jyc3 < 20 10/3/2006 Outperform NS $71.64 +350.78% +97.45% +253.33 0 Comment
XMFSean 99.57 9/15/2006 Outperform 3Y $71.77 +349.92% +97.43% +252.49 0 Comment
shortvest 93.41 9/14/2006 Outperform 5Y $71.57 +351.21% +99.98% +251.23 1 Comment
fitness100 83.50 8/28/2006 Outperform 3Y $71.14 +353.95% +103.15% +250.80 0 Comment
trothy 36.21 8/28/2006 Outperform 3Y $71.14 +353.95% +103.15% +250.80 0 Comment
CAPS5star1star 86.19 9/15/2006 Outperform NS $72.02 +348.39% +98.04% +250.35 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStandpoint 40.26 3/17/2016 Outperform 5Y $244.15 +11.23% +0.27% +10.96 4/5/2016 @ $271.56 0 Comment
TrackStandpoint 40.26 2/4/2015 Underperform 5Y $307.79 -7.94% -6.88% +1.06 1/13/2016 @ $283.36 0 Comment
TrackWayneRogers 59.17 3/29/2013 Outperform 3M $159.00 +103.10% +57.72% +45.38 0 Comment
TrackStandpoint 40.26 10/25/2012 Underperform 5Y $136.11 +64.69% +31.99% -32.69 4/4/2014 @ $224.16 0 Comment
TrackPoisedTo < 20 10/2/2012 Outperform 5Y $143.98 +124.28% +70.51% +53.77 0 Comment

Featured Broker Partners